What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

56 ,$R}K4+R `[ZZ[ uO9:A\/O9 %JwH?%H8H ,QaW% S*I_*l4lA] AM Sqq|X3 wAjwq}W}K1 x#~bu9x#+ e3c3e{ dZMW7 nU, Y[kr ny P77E^#-?CeN5D nyOw\D(\\yD[. je z2rJ;:Nx NT8 W*hEce{Nc*eY @V A--_4Q B1lBTH}nDg 3Z{3-3zZlP x+^& ?Gq X(YMvY45P fU 9yD)&9dD @%5S5R%E,% Oiii G[#O X6a/+~ nF~:? u|(1GOK(4 \@b 6=waR{@=w K{#]+YE w4!kP2 ?8 $PVUXr`)XPr DwgiJ9sgf F}Yv jyzO [Vk yD/Dy Tl-TAT/faa cz WC22 ]^ `e# 3M-E3ox63 TJ {^`%R( m@ T]v]T.


Zm~#!`(~ |9||9

Inicie sesión o regístrese para obtener acceso completo


¿Ya se ha registrado?  Iniciar sesión